Efficacy and Safety of Opicapone in Clinical Practice
Status:
Completed
Trial end date:
2018-07-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the change in subject's condition according to the
Investigator's Global Assessment of Change after three months of treatment with 50 mg
opicapone once daily in a heterogeneous patient population reflecting daily clinical
practice.